NCT07623798 2026-06-03A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003Innovent Biologics (Suzhou) Co. Ltd.Phase 3 Not yet recruiting255 enrolled
NCT02504489 2026-05-19DUBLIN-3BeyondSpring Pharmaceuticals Inc.Phase 3 Completed559 enrolled 32 charts